Chen Z X, Chen J P, Chen Z, Peng D S, Zhen J X, Tan J S
Zhi-Xing Chen, Jia-Ping Chen, Zhong Chen, De-Shu Peng, Ji-Xiang Zhen, Department of Surgery, First Affiliated Hospital, West China University of Medical Sciences, Chengdu 610041, Sichuan Province, China.
World J Gastroenterol. 1997 Dec 15;3(4):246-8. doi: 10.3748/wjg.v3.i4.246.
To study the therapeutic effect of intraperitoneal hyperthermic double-distilled water and cis-diaminodichloro-platinum (DDP) perfusion for cancerous ascites and radical gastrectomy.
LACA mice were injected peritoneally with H22 cancer cells (2 × 10(7) tumor cells). Five days later, the mice received treatments with either intraperitoneal perfusion of 37 °C isotonic fluid (group I), or 43 °C simple hyperthermic double-distilled water (group II), isotonic fluid (group III), DDP (group IV) or a combination of the hyperthermic double-distilled water with DDP (group V). A clinical experiment with intraperitoneal hyperthermic double-distilled water perfusion with DDP was carried out from September 1991 through September 1993 with 32 advanced gastric cancer patients who had undergone radical gastrectomy.
In comparison with the untreated control group of cancer cell-bearing LACA mice, the mice in all treatment groups showed near complete obliteration of cancer cells in the peritoneal cavity, markedly reduced ascites, prolonged survival times, and reduced growth of peritoneal cancerous nodes. In the clinical experiment, all 32 patients with advanced carcinoma had achieved satisfactory results at the 1-year follow-up, but had unsatisfactory results at the 2-year follow-up.
The intraperitoneal hyperthermic double-distilled water perfusion with DDP inhibited the occurrence of ascites in LACA mice bearing cancer cells, and prolonged the lifetime of patients with gastric cancer who had undergone radical gastrectomy.
研究腹腔内热双蒸水和顺铂(DDP)灌注治疗癌性腹水及根治性胃切除术的疗效。
给LACA小鼠腹腔注射H22癌细胞(2×10⁷个肿瘤细胞)。五天后,小鼠接受以下治疗:腹腔灌注37℃等渗液(I组)、43℃单纯热双蒸水(II组)、等渗液(III组)、DDP(IV组)或热双蒸水与DDP联合(V组)。1991年9月至1993年9月对32例接受根治性胃切除术的晚期胃癌患者进行了腹腔内热双蒸水联合DDP灌注的临床试验。
与未治疗的荷瘤LACA小鼠对照组相比,所有治疗组小鼠腹腔内癌细胞几乎完全消失,腹水明显减少,生存时间延长,腹膜癌结节生长减缓。在临床试验中,32例晚期癌患者在1年随访时均取得满意结果,但在2年随访时结果不理想。
腹腔内热双蒸水联合DDP灌注可抑制荷瘤LACA小鼠腹水的产生,并延长接受根治性胃切除术的胃癌患者的生存期。